Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick Mahlen O'Neil, Andreas L. Birkenfeld, Barbara M. McGowan, Ofri Mosenzon, Sue D. Pedersen, Sean Wharton, Charlotte Giwercman Carson, Cecilie Heerdegen Jepsen, Maria Kabisch, John P.H. Wilding
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s0140-6736(18)31773-2
- Published
- Aug 1, 2018
- Venue
- The Lancet
- DOI
- 10.1016/s0140-6736(18)31773-2
- PubMed
- 30122305
- Categories
- Pharmacology and Obesity Treatment
- Provenance
- openalex